Cancer prevention with aspirin in hereditary colorectal cancer (Lynch Syndrome), a 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double blind, randomised, placebo-controlled trial. Lancet 2020; 395: 1855-1863.
Published: 25th August 2020
Authors: Burn J, Sheth H, Elliott F, Reed L, Macrae F, Mecklin J-P et al.
Some 861 people were randomised between 1999 and 2005, and followed for a mean of ten years. Aspirin significantly reduced the risk of colorectal cancer: hazard ratio 0.65, 95 per cent confidence interval 0.43 to 0.97, P=0.35. Adverse event rates were similar.Pubmed Link
You may also be interested in
Effect of a deep-learning computer-aided detection system on adenoma detection during colonoscopy (CADE-DB trial): a double-blind randomised study. Lancet Gastroenterol Hepatol 2020; 5: 343-351.
Authors: Wang P, Liu X, Berzin TM, Glissen Brown JR, Liu P, Zhou C et al.
Modifiable pathways for colorectal cancer: a mendelian randomisation analysis. Lancet Gastroenterol Hepatol 2020; 5: 142-151
Authors: Cornish AJ, Law PJ, Tomofeeva M, Palin K, Farrington SM, Palles C et al.
Efficacy and safety of sodium picosulfate/magnesium citrate for bowel preparation in a physically disabled outpatient population: a randomized, endoscopist-blinded comparison with ascorbic acid-enriched polyethylene glycol solution plus bisacodyl (The PICO-MOVI Study). Dis Colon Rectum 2018; 61: 239-249.
Authors: Mathus-Vliegen E, van der Vliet K, Wignand-van der Storm IJ, Stadwijk J
Comparative evaluation of the efficacy of polyethylene glycol with ascorbic acid and an oral sulfate solution in a split method for bowel preparation: a randomized, multicenter phase III clinical trial. Dis Colon Rectum 2017; 60: 426-432.
Authors: Bun K, Lee SD, Han KS, Kim BC, Youk E-G, Nam MJ et al.
Split-dose preparation for colonoscopy increases adenoma detection rate: a randomised controlled trial in an organised screening programme. Gut 2017; 66: 270-277.
Authors: Paggi S, Hassan C, Senore C, Fasoli R, Anderloni A, Buffoli F et al.
Celecoxib for the prevention of colorectal adenomas: results of a suspended randomized controlled trial. J Natl Cancer Inst 2016; 108: djw151.
Authors: Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F et al.
Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia. BMJ 2016; 355: i6188.
Authors: Dulai PS, Singh S, Marquez E, Khera R, Prokop LJ, Limburg PJ et al.
Real-time optical diagnosis for diminutive colorectal polyps using narrow-band imaging: the VALID randomised clinical trial. Gut 2015; 64: 1569-1577.
Authors: Kaltenbach T, Rastogi A, Rouse RV, McQuaid KR, Sato T, Bansal A et al. et al.
Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis. Gut 2015; 64: 1419-1425.
Authors: Li P, Wu H, Zhang H, Shi Y, Xu J, Ye Y et al. et al.
A trial of calcium and vitamin D for the prevention of colorectal adenomas. N Engl J Med 2015; 373: 1519-1530.
Authors: Baron JA, Barry EL, Mott LA, Rees JR, Sandler RS, Snover DC et al. et al.
The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial. Gut 2014; 63: 1755-1759.
Authors: Ishikawa H, Mutoh M, Suzuki S, Tokudome S, Saida Y, Abe T et al. et al.
Randomized clinical trial comparing reduced-volume oral picosulphate and a prepackaged low-residue diet with 4-liter PEG solution for bowel preparation. Dis Colon Rectum 2014; 57: 522-528.
Authors: Kim Ys, Hong CW, Kim BC, Han KS, Park JW, Seong Choi H et al. et al.